Software Oversight Softened: FDA Nixes Medical Device Data Systems Enforcement
This article was originally published in The Gray Sheet
Executive Summary
Makers of software that passively stores, transfers, formats or displays medical device data no longer need to worry about the quality system regulation or other basic device requirements for the products, according to a June 20 draft guidance.
You may also be interested in...
FDA Officially Halts Oversight Of Passive Device Data Systems
FDA cemented its plan in guidance not to regulate medical device data systems in a bid to boost innovation in the industry.
Active Months Ahead For mHealth Regulatory Policymaking
Multiple guidances, frameworks and legislative activity on mHealth are expected to surface this fall and could have major implications on how the emerging industry is regulated.
Stakeholders Ask FDA For Clarity, Rule Cementing Data Systems Downgrade
Industry representatives and patient advocacy groups say they support FDA’s decision to refrain from regulating medical device data systems but want further clarification and a rule to more explicitly state the agency’s intentions.